BAX - Baxter International Inc.
NYSE
->
Healthcare
->
Medical Instruments & Supplies
Deerfield,
United States
Type: Equity
BAX price evolution
BAX
| (in millions $) | 31 Dec 2023 | 30 Oct 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $3194 | $5788 | $1722 | $1673 |
| Short term investments | ||||
| Net receivables | $2690 | $2553 | $2495 | $2547 |
| Inventory | $2824 | $2873 | $2897 | $2922 |
| Total current assets | $9600 | $12034 | $8205 | $8099 |
| Long term investments | ||||
| Property, plant & equipment | $4957 | $4797 | $5027 | $5554 |
| Goodwill & intangible assets | $12593 | $12637 | $12888 | $13508 |
| Total noncurrent assets | $18676 | $18622 | $19680 | $20192 |
| Total investments | ||||
| Total assets | $28276 | $30656 | $27885 | $28291 |
| Current liabilities | ||||
| Accounts payable | $1241 | $1246 | $1240 | $1290 |
| Deferred revenue | ||||
| Short long term debt | $2668 | $2426 | $2177 | $1153 |
| Total current liabilities | $6503 | $6209 | $5765 | $4760 |
| Long term debt | $11568 | $14067 | $14744 | $15736 |
| Total noncurrent liabilities | $13305 | $16281 | $16489 | $17590 |
| Total debt | $14236 | $16929 | $16921 | $16889 |
| Total liabilities | $19808 | $22555 | $22254 | $22350 |
| Shareholders' equity | ||||
| Retained earnings | $16114 | $16015 | $13655 | $13947 |
| Other shareholder equity | -$3554 | -$3716 | -$3814 | -$3739 |
| Total shareholder equity | $8402 | $8101 | $5569 | $5879 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $3194 | $1718 | $2951 | $3730 |
| Short term investments | ||||
| Net receivables | $2690 | $2752 | $2629 | $2077 |
| Inventory | $2824 | $2718 | $2453 | $1916 |
| Total current assets | $9600 | $8011 | $8872 | $8411 |
| Long term investments | $135 | |||
| Property, plant & equipment | $4957 | $5529 | $5808 | $5325 |
| Goodwill & intangible assets | $12593 | $13636 | $17628 | $4888 |
| Total noncurrent assets | $18676 | $20276 | $24649 | $11608 |
| Total investments | ||||
| Total assets | $28276 | $28287 | $33521 | $20019 |
| Current liabilities | ||||
| Accounts payable | $1241 | $1139 | $1246 | $2927 |
| Deferred revenue | ||||
| Short long term debt | $2668 | $1404 | $511 | $406 |
| Total current liabilities | $6503 | $4745 | $4236 | $3333 |
| Long term debt | $11568 | $15232 | $17671 | $6287 |
| Total noncurrent liabilities | $13305 | $17647 | $20164 | $7960 |
| Total debt | $14236 | $17092 | $18182 | $6693 |
| Total liabilities | $19808 | $22454 | $24400 | $11293 |
| Shareholders' equity | ||||
| Retained earnings | $16114 | $14050 | $17065 | $16328 |
| Other shareholder equity | -$3554 | -$3833 | -$3380 | -$3314 |
| Total shareholder equity | $8402 | $5833 | $9077 | $8689 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3885 | $3708 | $3707 | $3649 |
| Cost of revenue | $2413 | $2591 | $2596 | $2302 |
| Gross Profit | $1472 | $1117 | $1111 | $1347 |
| Operating activities | ||||
| Research & development | $172 | $166 | $165 | $164 |
| Selling, general & administrative | $985 | $1002 | $964 | $1010 |
| Total operating expenses | $1143 | $1168 | $1128 | $1161 |
| Operating income | $329 | -$51 | -$17 | $186 |
| Income from continuing operations | ||||
| EBIT | $483 | $2413 | -$7 | $186 |
| Income tax expense | $165 | -$223 | $10 | $25 |
| Interest expense | $73 | $128 | $124 | $117 |
| Net income | ||||
| Net income | $245 | $2508 | -$141 | $44 |
| Income (for common shares) | $245 | $2508 | -$141 | $44 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $14813 | $15113 | $12784 | $11673 |
| Cost of revenue | $9838 | $9716 | $7679 | $7086 |
| Gross Profit | $4975 | $5397 | $5105 | $4587 |
| Operating activities | ||||
| Research & development | $667 | $605 | $534 | $521 |
| Selling, general & administrative | $3946 | $3887 | $2867 | $2469 |
| Total operating expenses | $4585 | $7340 | $3395 | $2971 |
| Operating income | $390 | -$1943 | $1710 | $1616 |
| Income from continuing operations | ||||
| EBIT | $3064 | -$1970 | $1658 | $1418 |
| Income tax expense | -$34 | $68 | $182 | $182 |
| Interest expense | $442 | $395 | $192 | $134 |
| Net income | ||||
| Net income | $2656 | -$2433 | $1284 | $1102 |
| Income (for common shares) | $2656 | -$2433 | $1284 | $1102 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $245 | $2508 | -$141 | $44 |
| Operating activities | ||||
| Depreciation | $324 | $311 | $309 | $319 |
| Business acquisitions & disposals | -$3 | -$3 | ||
| Stock-based compensation | $30 | $41 | $37 | $25 |
| Total cash flows from operations | $531 | $365 | $351 | $479 |
| Investing activities | ||||
| Capital expenditures | -$190 | -$174 | -$156 | -$172 |
| Investments | ||||
| Total cash flows from investing | -$230 | $3786 | -$173 | -$170 |
| Financing activities | ||||
| Dividends paid | -$147 | -$147 | -$146 | -$146 |
| Sale and purchase of stock | $9 | $32 | $18 | $36 |
| Net borrowings | -$2794 | $54 | $59 | -$252 |
| Total cash flows from financing | -$2935 | -$62 | -$120 | -$372 |
| Effect of exchange rate | $40 | -$23 | -$9 | $18 |
| Change in cash and equivalents | -$2594 | $4066 | $49 | -$45 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $2656 | -$2433 | $1284 | $1102 |
| Operating activities | ||||
| Depreciation | $1263 | $1403 | $890 | $823 |
| Business acquisitions & disposals | -$6 | -$263 | -$10502 | -$494 |
| Stock-based compensation | $133 | $154 | $146 | $130 |
| Total cash flows from operations | $1726 | $1211 | $2222 | $1868 |
| Investing activities | ||||
| Capital expenditures | -$692 | -$679 | -$743 | -$709 |
| Investments | ||||
| Total cash flows from investing | $3213 | -$931 | -$11200 | -$1179 |
| Financing activities | ||||
| Dividends paid | -$586 | -$573 | -$530 | -$473 |
| Sale and purchase of stock | $95 | $95 | -$413 | -$298 |
| Net borrowings | -$2933 | -$899 | $9228 | $478 |
| Total cash flows from financing | -$3489 | -$1438 | $8245 | -$345 |
| Effect of exchange rate | $26 | -$76 | -$47 | $57 |
| Change in cash and equivalents | $1476 | -$1234 | -$780 | $401 |
News
Fundamentals
| Market cap | $20.13B |
|---|---|
| Enterprise value | $31.17B |
| Shares outstanding | 507.63M |
| Revenue | $14.95B |
|---|---|
| EBITDA | $4.34B |
| EBIT | $3.08B |
| Net Income | $2.66B |
| Revenue Q/Q | -0.05% |
| Revenue Y/Y | -1.09% |
| P/E ratio | 7.58 |
|---|---|
| EV/Sales | 2.09 |
| EV/EBITDA | 7.19 |
| EV/EBIT | 10.14 |
| P/S ratio | 1.35 |
| P/B ratio | 1.68 |
| Book/Share | 23.55 |
| Cash/Share | 6.29 |
| EPS | $5.23 |
|---|---|
| ROA | 9.23% |
| ROE | 38.01% |
| Debt/Equity | 2.36 |
|---|---|
| Net debt/EBITDA | 3.83 |
| Current ratio | 1.48 |
| Quick ratio | 1.04 |